CD24Fc for prevention of GVHD; origins of active EBV disease; the role of PF4 in platelet activation
Release Date:
In this week's episode we’ll discuss the findings from a phase 2 study of CD24Fc for prevention of graft-versus-host disease, learn more about the origins of chronic active Epstein-Barr virus disease, and discuss the role of PF4 in platelet activation.
CD24Fc for prevention of GVHD; origins of active EBV disease; the role of PF4 in platelet activation